| Literature DB >> 36105867 |
Shamima Islam Nipa1,2, Thanyaluck Sriboonreung1, Aatit Paungmali1, Chailert Phongnarisorn3.
Abstract
Aim: To compare the combined effects of core stability exercise and pelvic floor muscle exercise (PFME) with the effects of PFME alone on women with stress urinary incontinence (SUI) who experience nonspecific chronic low back pain (NSCLBP).Entities:
Year: 2022 PMID: 36105867 PMCID: PMC9467742 DOI: 10.1155/2022/2051374
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
Figure 1Consolidated Standards of Reporting Trials (CONSORT) flow diagram.
Baseline characteristics of the respondents.
| Variables | PFME + core stability group (mean; SD ±) | PFME group (mean; SD ±) |
|
|---|---|---|---|
| Age (years) | 41.00 (±9.07) | 40.84 (±8.82) | 0.684 |
| BMI (kg/m2) | 28.90 (±6.81) | 27.20 (±6.02) | 0.657 |
| Level of exercise | 1.96 (±0.84) | 1.88 (±0.83) | 0.902 |
| Pad test at baseline (g) | 10.36 (±4.29) | 10.36 (±3.93) | 0.513 |
| VAS score (10 mm) | 3.44 (±2.00) | 3.76 (±1.85) | 0.604 |
| ISI frequency | 2.68 (±1.10) | 2.08(±0.95) | 0.144 |
| ISI amount | 2.28 (±0.68) | 2.08 (±0.49) | 0.113 |
| QoL (GH) | 45.00 (±31.45) | 28.00 (±19.52) | 0.092 |
| QoL (II) | 49.29 (±16.96) | 47.96 (±16.85) | 0.618 |
| QoL (RL) | 29.29 (±16.87) | 28.62 (±17.69) | 0.893 |
| QoL (PhyL) | 30.62 (±15.73) | 32.62 (±12.26) | 0.088 |
| QoL (SL) | 11.54 (±3.41) | 11.98 (±2.94) | 0.447 |
| QoL (PR) | 21.65 (±10.28) | 30.64 (±11.96) | 0.311 |
| QoL (EM) | 37.74 (±7.01) | 27.97 (±7.14) | 0.524 |
| QoL (SE) | 4.65 (±1.25) | 10.64 (±3.46) | 0.896 |
Em: emotion; GH: general health; II: incontinence impact; ISI: incontinence severity index; PBU: pressure biofeedback unit; PhyL: physical limitation; PR: personal relationships; QoL: quality of life; RL: role limitation; SE: sleep energy; SL: social limitation; and SM: severity measure. Student's t-test
The mean pad weight of the experimental and control groups at each week of intervention.
| Measurement week | PFME + core stability mean (±SD) (g); | Mean (±SD) (g); |
|---|---|---|
| Pad test at baseline | 10.36 (±4.29); | 10.36 (±3.93); |
| Pad test in the 4th week | 7.04 (±3.01); | 8.66 (±3.51); |
| (pad's weight <2 grams; | (pad's weight<2 grams; | |
| Pad test in the 8th week | 4.06 (±2.10); | 8.16 (±3.09); |
| (pad's weight <2 grams; | (pad's weight <2 grams; | |
| Pad test in the 12th week | 1.36 (±1.09); | 6.62 (±3.19); |
| (pad's weight <2 grams; | (pad's weight <2 grams; | |
| Cure (%; | 72% ( | 28% ( |
PFMT: pelvic floor muscle training and SD: standard deviation. n#: total number of continent patients.
Difference of pad weight in between the study groups after the 12th week of intervention.
| Variable | PFME+ core stability exercise (mean; ±SD) (g) | PFME (mean; ±SD) (g) |
|
|---|---|---|---|
| Pad test weight at baseline | 10.36 (±4.29) | 10.36 (±3.93) |
|
| Pad test weight after the 12th week of intervention | 1.36 (±1.09) | 6.62 (±3.19) |
PFMT: pelvic floor muscle training. Level of significance within the groups p < 0.007. Level of significance in between the groups (2 × 2 repeated measures ANOVA test).
Incontinence severity index after the 12th week of intervention.
| Variable | PFME + core stability | PFME |
|
|---|---|---|---|
| UI frequency at baseline | 6.32 (±3.77) | 4.60 (±2.88) | 0.014 |
| UI frequency in the 12th week of intervention | 0.76 (±1.01) | 2.04 (±1.76) |
PFMT: pelvic floor muscle training. Level of significance within the groups (p < 0.008). Level of significance in between the groups (2 × 2 repeated measures ANOVA test).
Secondary outcome of the intervention of both groups.
| PFME + core stability exercise (mean; SD ±) | PFME (mean; SD ±) | Level of significance in between the groups | |
|---|---|---|---|
| Part I | |||
|
| |||
|
| |||
| Baseline | 45 (±31.45) | 28 (±19.52) | 0.291 |
| After the 12th week of intervention | 18 (±18.42) | 11 (±14.57) | |
|
| |||
|
| |||
| Baseline | 49.29 (±16.96) | 47.96 (±16.85) | 0.000 |
| After the 12th week of intervention | 14.52 (±16.71) | 29.04 (±23.94) | |
|
| |||
| Part II | |||
|
| |||
|
| |||
| Baseline | 29.29 (±16.87) | 28.62 (±17.69) | 0.000 |
| In the 12th week of intervention | 11.30 (±13.34) | 17.96 (±15.89) | |
|
| |||
|
| |||
| Baseline | 30.62 (±15.73) | 32.62 (±12.26) | 0.000 |
| 12th week of intervention | 11.30 (±12.45) | 22.62 (±12.62) | |
|
| |||
|
| |||
| Baseline | 11.54 (±13.39) | 11.98 (±11.51) | 0.344 |
| 12th week of intervention | 4.88 (±10.17) | 3.99 (±8.99) | |
|
| |||
|
| |||
| Baseline | 18.65 (±28.98) | 30.64 (±25.29) | 0.613 |
| 12th week of intervention | 14.64 (±24.19) | 25.97 (±21.01) | |
|
| |||
|
| |||
| Baseline | 37.74 (±13.21) | 27.97 (±15.73) | 0.725 |
| 12th week of intervention | 27.08 (±13.99) | 16.42 (±12.45) | |
|
| |||
|
| |||
| Baseline | 4.65 (±10.21) | 10.64 (±14.32) | 0.177∗∗ |
| 12th week of intervention | 3.65 (±8.34) | 6.65 (±11.76) | |
|
| |||
|
| |||
| Baseline | 43.96 (±9.18) | 50.64 (±9.60) | 0.000 |
| 12th week of intervention | 31.63 (±8.99) | 36.63 (±12.01) | |
|
| |||
| Part III | |||
|
| |||
| How much bladder problem affect? | |||
| Baseline | 8.40 (±0.957) | 9.36 (±1.11) | 0.000 |
| 12th week of intervention | 4.40 (±1.41) | 7.32 (±1.14) | |
PFMT: pelvic floor muscle training. Level of significance within the groups (P ≤ 0.001). Level of significance in between the groups (2 × 2 repeated measures ANOVA test).